ASX Announcements

23 May 2022

Artificial Intelligence to Advance NTCELL Production

Living Cell Technologies (ASX:LCT) is entering a new phase in its research, with artificial intelligence to be applied to the company’s groundbreaking research to combat Parkinson’s disease. 

3 May 2022

Application for Quotation of Securities - LCT

Application for quotation of securities (ASX:LCTOA) - options expiring 19 April 2024.

2 May 2022

Living Insights Newsletter - May 2022

LCT's "Living Insights" newsletter for May 2022 provides a behind-the-scenes look at the company and our latest activities, including interviews with our new COO, Dr Belinda Di Bartolo and NZeno CEO Paul Tan.

29 April 2022

Quarterly Activity Report and Appendix 4C

Quarterly Activity Report and Appendix 4C for the March quarter 2022, highlighted by the planned first production of NTCELL in Australia.

28 April 2022

Chairman's Address - Extraordinary General Meeting

Chairman's address to the Extraordinary General Meeting held virtually on 28 April 2022.